Actively Recruiting
International Multicenter Study Comparing Staged Bilateral Exablate Thalamotomy with Standard Care in Essential Tremor Patients
Led by InSightec · Updated on 2026-08-31
100
Participants Needed
13
Research Sites
34 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the added benefits of staged bilateral Exablate thalamotomy compared to previous unilateral treatment combined with local standard medical treatment in patients with Essential Tremor. This Phase IV, randomized, controlled, and blinded multicenter study aims to measure the effects on tremor reduction, functional impairment, quality of life, adverse events, and patient perception of treatment outcomes. Participants assigned to the treatment group will receive staged bilateral Exablate thalamotomy, while those in the control group will continue with their local standard medical care after prior unilateral thalamotomy. The main goal is to show whether the bilateral procedure reduces tremor more effectively than unilateral treatment at 6 months. During the study, participants will undergo assessments including tremor severity ratings using the Clinical Rating Scale for Tremor, quality of life questionnaires, and safety monitoring for adverse events. These evaluations occur at 6 and 12 months after treatment or continued care. Participants are expected to remain in the study for at least 6 months to complete all required assessments.
CONDITIONS
Brief Title
EMBRACE Tremor BiFUS
Research Team
P
Pascalle Reiters
I
Insightec
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here